198904-31-3 Atazanavir AKSci R133
 
 
Loading Please Wait...
  R133    AKSci Reference Standard
Atazanavir
, 98% (HPLC)
 
Latazanavir
Zrivada
Reyataz
more..




IDENTITY
CAS Number:198904-31-3
MDL Number:MFCD08435966
MF:C38H52N6O7
MW:704.86
SPECIFICATIONS & PROPERTIES
Purity:98% (HPLC)
Spectra:NMR, LCMS, FT-IR, HPLC, Polarimetry
Physical Form:White to beige powder or solid
Melting Point:203-209°C
Optical Rotation:-47° to -37° (c=1, EtOH)
Long-Term Storage:Store long-term at -20°C

BIOLOGICAL INFO
Application(s):Anti-HIV Agent; HIV Protease Inhibitor
Form:Free Base

REVIEW

 Atazanavir selectively inhibits the virus-specific processing of viral Gag and Gag-Pol polyproteins in HIV-1 infected cells by binding to the active site of HIV-1 protease, thus preventing the formation of mature virions. Atazanavir is not active against HIV-2.

REFERENCES
[1]Croom KF, Dhillon S, Keam SJ: Atazanavir: a review of its use in the management of HIV-1 infection. Drugs. 2009 May 29;69(8):1107-40. doi: 10.2165/00003495-200969080-00009.
[2] von Hentig N: Atazanavir/ritonavir: a review of its use in HIV therapy. Drugs Today (Barc). 2008 Feb;44(2):103-32.
[3] Swainston Harrison T, Scott LJ: Atazanavir: a review of its use in the management of HIV infection. Drugs. 2005;65(16):2309-36.
[4] Le Tiec C, Barrail A, Goujard C, Taburet AM: Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin Pharmacokinet. 2005;44(10):1035-50.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


RELATED PRODUCTS
N349Atazanavir sulfate
R133Atazanavir

Current as of July 8, 2020

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES

 APIs and Bioactives > Antivirals, Antiretrovirals, HIV Protease Inhibitors


PubChem